Agonist-specific patterns of β(2)-adrenoceptor responses in human airway cells during prolonged exposure

Por Düringer, Caroline, Grundström, Gunilla, Gürcan, Eylem, Dainty, Ian A, Lawson, Mandy, Korn, Solange H, Jerre, Anders, Håkansson, Hanna Falk, Wieslander, Elisabet, Fredriksson, Karin, Sköld, Carl Magnus, Löfdahl, Magnus, Löfdahl, Claes-Göran, Nicholls, David J, Silberstein, David S
Publicado em 2009

Discovery of AZD3199, An Inhaled Ultralong Acting β(2) Receptor Agonist with Rapid Onset of Action

Por Stocks, Michael J., Alcaraz, Lilian, Bailey, Andrew, Bonnert, Roger, Cadogan, Elaine, Christie, Jadeen, Dixon, John, Connolly, Stephen, Cook, Anthony, Fisher, Adrian, Flaherty, Alice, Humphries, Alexander, Ingall, Anthony, Jordan, Stephen, Lawson, Mandy, Mullen, Alex, Nicholls, David, Paine, Stuart, Pairaudeau, Garry, Young, Alan
Publicado em 2014

Activating ESR1 mutations differentially impact the efficacy of ER antagonists

Por Toy, Weiyi, Weir, Hazel, Razavi, Pedram, Lawson, Mandy, Goeppert, Anne U, Mazzola, Anne Marie, Smith, Aaron, Wilson, Joanne, Morrow, Christopher, Wong, Wai Lin, De Stanchina, Elisa, Carlson, Kathryn E., Martin, Teresa S., Uddin, Sharmeen, Li, Zhiqiang, Fanning, Sean, Katzenellenbogen, John A., Greene, Geoffrey, Baselga, Jośe, Chandarlapaty, Sarat
Publicado no Cancer Discov (2016)